Characterization of autoimmune inflammation induced prostate stem cell expansion

Prostate

Volumn 75, Issue 14, 2015, Pages 1620-1631

  Wang, Hsing Hui ^a,b   Wang, Liang ^c   Jerde, Travis J ^c   Chan, Bin Da ^b   Savran, Cagri A ^b   Burcham, Grant N ^a   Crist, Scott ^a,b   Ratliff, Timothy L ^a,b  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

inflammation; prostate biology; prostate stem cells

Indexed keywords

CYTOKERATIN 5; CYTOKERATIN 8; EOSIN; HEMATOXYLIN; OVALBUMIN;

ANIMAL CELL; ARTICLE; CD31- SCA1+ CD49F+ T LYMPHOCYTE; CD45- SCA1+ CD49F+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL EXPANSION; T LYMPHOCYTE; ANIMAL; AUTOIMMUNITY; C57BL MOUSE; CANCER STEM CELL; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TRANSGENIC MOUSE;

ANIMALS; AUTOIMMUNITY; CELL PROLIFERATION; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; PROSTATIC NEOPLASMS;

EID: 84939186940     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.23043     Document Type: Article

References (47)

1. Bastian PJ, Yegnasubramanian S, Palapattu GS, Rogers CG, Lin X, De Marzo AM, Nelson WG,. Molecular biomarker in prostate cancer: The role of CpG island hypermethylation. Eur Urol 2004; 46 (6): 698-708.
2. De Marzo AM, Nakai Y, Nelson WG,. Inflammation, atrophy, and prostate carcinogenesis. Urol Oncol 2007; 25 (5): 398-400.
3. Haverkamp JM, Charbonneau B, Crist SA, Meyerholz DK, Cohen MB, Snyder PW, Svensson RU, Henry MD, Wang HH, Ratliff TL,. An inducible model of abacterial prostatitis induces antigen specific inflammatory and proliferative changes in the murine prostate. Prostate 2011; 71 (11): 1139-1150.
4. Sfanos KS, De Marzo AM,. Prostate cancer and inflammation: The evidence. Histopathology 2012; 60 (1): 199-215.
5. Coussens LM, Werb Z,. Inflammation and cancer. Nature 2002; 420 (6917): 860-867.
6. Haverkamp J, Charbonneau B, Ratliff TL,. Prostate inflammation and its potential impact on prostate cancer: A current review. J Cell Biochem 2008; 103 (5): 1344-1353.
7. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON,. Identification of a cell of origin for human prostate cancer. Science 2010; 329 (5991): 568-571.
8. English HF, Santen RJ, Isaacs JT,. Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 1987; 11 (3): 229-242.
9. Isaacs JT, Coffey DS,. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl 1989; 2: 33-50.
10. Isaacs JT,. Prostate stem cells and benign prostatic hyperplasia. Prostate 2008; 68 (9): 1025-1034.
11. Sun B, Karin M,. Inflammation and liver tumorigenesis. Front Med 2013; 7 (2): 242-254.
12. Kwon OJ, Zhang L, Ittmann MM, Xin L,. Prostatic inflammation enhances basal-to-luminal differentiation and accelerates initiation of prostate cancer with a basal cell origin. Proc Natl Acad Sci USA 2014; 111 (5): E592-E600.
13. Nagle RB, Ahmann FR, McDaniel KM, Paquin ML, Clark VA, Celniker A,. Cytokeratin characterization of human prostatic carcinoma and its derived cell lines. Cancer Res 1987; 47 (1): 281-286.
14. Verhagen AP, Ramaekers FC, Aalders TW, Schaafsma HE, Debruyne FM, Schalken JA,. Colocalization of basal and luminal cell-type cytokeratins in human prostate cancer. Cancer Res 1992; 52 (22): 6182-6187.
15. Sherwood ER, Berg LA, Mitchell NJ, McNeal JE, Kozlowski JM, Lee C,. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol 1990; 143 (1): 167-171.
16. Verhagen AP, Aalders TW, Ramaekers FC, Debruyne FM, Schalken JA,. Differential expression of keratins in the basal and luminal compartments of rat prostatic epithelium during degeneration and regeneration. Prostate 1988; 13 (1): 25-38.
17. Hudson DL, Guy AT, Fry P, O'Hare MJ, Watt FM, Masters JR,. Epithelial cell differentiation pathways in the human prostate: Identification of intermediate phenotypes by keratin expression. J Histochem Cytochem 2001; 49 (2): 271-278.
18. van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA, De Marzo AM,. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 2003; 162 (5): 1529-1537.
19. Senoo M, Pinto F, Crum CP, McKeon F,. P63 Is essential for the proliferative potential of stem cells in stratified epithelia. Cell 2007; 129 (3): 523-536.
20. Pignon JC, Grisanzio C, Geng Y, Song J, Shivdasani RA, Signoretti S,. P63-expressing cells are the stem cells of developing prostate, bladder, and colorectal epithelia. Proc Natl Acad Sci USA 2013; 110 (20): 8105-8110.
21. Khalili M, Mutton LN, Gurel B, Hicks JL, De Marzo AM, Bieberich CJ,. Loss of Nkx3. 1 expression in bacterial prostatitis: A potential link between inflammation and neoplasia. Am J Pathol 2010; 176 (5): 2259-2268.
22. Zhang JF, Thomas TZ, Kasper S, Matusik RJ,. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000; 141 (12): 4698-4710.
23. Lukacs RU, Goldstein AS, Lawson DA, Cheng D, Witte ON,. Isolation, cultivation and characterization of adult murine prostate stem cells. Nat Protoc 2010; 5 (4): 702-713.
24. Lawson DA, Xin L, Lukacs RU, Cheng D, Witte ON,. Isolation and functional characterization of murine prostate stem cells. Proc Natl Acad Sci USA 2007; 104 (1): 181-186.
25. Xin L, Lukacs RU, Lawson DA, Cheng D, Witte ON,. Self-renewal and multilineage differentiation in vitro from murine prostate stem cells. Stem Cells 2007; 25 (11): 2760-2769.
26. Lees JR, Charbonneau B, Hayball JD, Diener K, Brown M, Matusik R, Cohen MB, Ratliff TL,. T-cell recognition of a prostate specific antigen is not sufficient to induce prostate tissue destruction. Prostate 2006; 66 (6): 578-590.
27. Lees JR, Charbonneau B, Swanson AK, Jensen R, Zhang J, Matusik R, Ratliff TL,. Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology 2006; 117 (2): 248-261.
28. Hahn AM, Myers JD, McFarland EK, Lee S, Jerde TJ,. Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasia. J Pharmacol Exp Ther 2014; 351 (3): 605-615.
29. Burcham GN, Cresswell GM, Snyder PW, Chen L, Liu X, Crist SA, Henry MD, Ratliff TL,. Impact of prostate inflammation on lesion development in the POET3(+) Pten(+/-) mouse model of prostate carcinogenesis. Am J Pathol 2014; 184 (12): 3176-3191.
30. Chan BD, Mateen F, Chang CL, Icoz K, Savran CA,. A compact manually actuated micromanipulator. J Microelectromech Syst 2012; 21 (1): 7-9.
31. Chan BD, Icoz K, Gieseck RL, Savran CA,. Selective weighing of individual microparticles using a hybrid micromanipulator-nanomechanical resonator system. Ieee Sensors J 2013; 13 (8): 2857-2862.
32. Chan BD, Icoz K, Huang W, Chang CL, Savran CA,. On-demand weighing of single dry biological particles over a 5-order-of-magnitude dynamic range. Lab Chip 2014; 14 (21): 4188-4196.
33. Fischer H, Polikarpov I, Craievich AF,. Average protein density is a molecular-weight-dependent function. Protein Sci 2004; 13 (10): 2825-2828.
34. Wang W, Bergh A, Damber JE,. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. Prostate 2009; 69 (13): 1378-1386.
35. De Marzo AM, Marchi VL, Epstein JI, Nelson WG,. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999; 155 (6): 1985-1992.
36. Habermacher GM, Chason JT, Schaeffer AJ,. Prostatitis/chronic pelvic pain syndrome. Annu Rev Med 2006; 57: 195-206.
37. Motrich RD, Maccioni M, Molina R, Tissera A, Olmedo J, Riera CM, Rivero VE,. Presence of INFgamma-secreting lymphocytes specific to prostate antigens in a group of chronic prostatitis patients. Clin Immunol 2005; 116 (2): 149-157.
38. Zhang J, Thomas TZ, Kasper S, Matusik RJ,. A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo. Endocrinology 2000; 141 (12): 4698-4710.
39. Kurts C, Heath WR, Carbone FR, Allison J, Miller JF, Kosaka H,. Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996; 184 (3): 923-930.
40. Mohler JL,. Concept and viability of androgen annihilation for advanced prostate cancer. Cancer 2014; 120 (17): 2628-2637.
41. Sykulev Y, Joo M, Vturina I, Tsomides TJ, Eisen HN,. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 1996; 4 (6): 565-571.
42. Matusik RJ, Jin RJ, Sun Q, Wang Y, Yu X, Gupta A, Nandana S, Case TC, Paul M, Mirosevich J,. Prostate epithelial cell fate. Differentiation 2008; 76 (6): 682-698.
43. Naylor AJ, Filer A, Buckley CD,. The role of stromal cells in the persistence of chronic inflammation. Clin Exp Immunol 2013; 171 (1): 30-35.
44. Katoh M,. STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer (Review). Int J Mol Med 2007; 19 (2): 273-278.
45. Wang J, Zhu HH, Chu M, Liu Y, Zhang C, Liu G, Yang X, Yang R, Gao WQ,. Symmetrical and asymmetrical division analysis provides evidence for a hierarchy of prostate epithelial cell lineages. Nat Commun 2014; 5: 4758.
46. Polson ES, Lewis JL, Celik H, Mann VM, Stower MJ, Simms MS, Rodrigues G, Collins AT, Maitland NJ,. Monoallelic expression of TMPRSS2/ERG in prostate cancer stem cells. Nat Commun 2013; 4: 1623.
47. Iliopoulos D, Hirsch HA, Struhl K,. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 2009; 139 (4): 693-706.